A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Cross‑Species‑Specific Single Domain Bispecific Single Chain Antibody
U.S. Patent No. 11,098,998 B2 What This Patent Covers This patent protects a single‑chain bispecific antibody construct — a specially engineered protein that: Such bispecific antibodies can simultaneously engage two different biological targets (e.g., a tumor cell antigen…
-
Spatially Encoded Biological Assays
U.S. Patent No. 11,008,607 B2 Issued: May 18, 2021Assignee: Likely assigned to parties involved in spatial genomics (the underlying family includes foundational work on spatially encoded assays that Illumina has been engaged with for spatial biology tools)Focus: Technologies for…
-
Adjuvant Treatment of HER2‑Positive Early Breast Cancer
U.S. Patent No. 11,077,189 B2 Assigned to: Genentech, Inc. (part of Roche)Issued: August 3, 2021Focus: Methods of using the monoclonal antibody pertuzumab in combination with other therapies for improved treatment outcomes in HER2‑positive early breast cancer. What This Patent…
BioTech IP Review 